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Abstract
Exercise training (ET) and hormone replacement therapy (HRT) are both recognized influences on
insulin action, but the influence of HRT on responses to ET has not been examined. In order to
determine if HRT use provided additive benefits for the response of insulin action to ET, we evaluated
the impact of HRT use on changes in insulin during the course of a randomized, controlled, aerobic
ET intervention. Subjects at baseline were sedentary, dyslipidemic, and overweight. These
individuals were randomized to six months of one of three aerobic ET interventions or continued
physical inactivity. In 206 subjects, an insulin sensitivity index (SI) was obtained with a frequently
sampled intravenous glucose tolerance test pre- and post-ET. Baseline and post-intervention fitness,
regional adiposity, general adiposity, skeletal muscle biochemistry and histology, and serum
lipoproteins were measured as other putative mediators influencing insulin action. Two-way analyses
of variance were used to determine if gender or HRT use influenced responses to exercise training.
Linear modeling was used to determine if predictors for response in SI differed by gender or HRT
use. Women who used HRT (HRT+) demonstrated significantly greater improvements in SI with ET
than women not using HRT (HRT?). In those HRT+ women, plasma triglyceride change best
correlated with change in SI. For HRT? women, capillary density change, and for men, subcutaneous
adiposity change, best correlated with change in SI. In summary, in an ET intervention, HRT use
appears associated with more robust responses in insulin action. Also, relationships between ET-
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induced changes in insulin action and potential mediators of change in insulin action are different
for men, and for women on or off HRT. These findings have implications for the relative utility of
ET for improving insulin action in middle-aged men and women, particularly in the setting of
differences in HRT use.
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With the increasing prevalence of obesity and type 2 diabetes, efforts are focused on
understanding the underlying pathogenesis of insulin resistance and how to improve insulin
action with lifestyle efforts[1]. It is well recognized that physical activity improves insulin
action, reduces adiposity, enhances cardiorespiratory fitness, and induces a favorable
lipoprotein particle distribution[2–5]. Also, exercise training has been found to alter a number
of skeletal muscle parameters that may impact insulin action and glucose disposal[6–8].
In addition to exercise training, in post-menopausal women, HRT use can improve insulin
action as well as adiposity, LDL and HDL cholesterol, and lean body mass[9] despite
paradoxical, yet clear evidence that chronic HRT use promotes adverse cardiovascular events
[10–12]. Previously, we reported observations regarding the impact of specific exercise
prescription effects on insulin sensitivity[2], where improvements with aerobic training were
most dependent on the time spent training rather than the intensity of training in men and post-
menopausal women. Here, in the context of a randomized controlled aerobic exercise
intervention, STRRIDE (Studies of Targeted Risk Reduction Through Defined Exercise), our
objective was to determine the impact of HRT use on insulin action response to exercise
training. A secondary objective was to determine if physiologic characteristics unique to each
group might account for any gender or HRT use differences in response in insulin action. Given
that both exercise training and HRT use are associated with improvements in insulin action,
we hypothesized that the combination of both would produce more robust responses in insulin
sensitivity.
Research Design and Methods
Study Design
Detailed descriptions of the STRRIDE design, including subject recruitment, randomization,
exercise training, and outcome variable measurements have been published elsewhere[13].
Relevant institutional review boards approved the research protocol, and informed consent was
obtained from all subjects.
Recruitment
Subjects were recruited with newspaper advertisements and through a network of
communication in the institutions involved. Subjects were nominally reimbursed for
participation in data collection, but the main inducement for participation was the opportunity
to participate in exercise training at no cost.
Subjects
Inclusion criteria were physical inactivity (not participating in regular exercise), overweight
to mild obesity (BMI 25–35 kg/m2), dyslipidemia (LDL-cholesterol of 130 to 190 mg/dl or
HDL-cholesterol < 40 mg/dl for men and < 45 mg/dl for women), and age between 40 and 69.
All women were post-menopausal with verification by subject confirmation of no menses in
the six months prior to study enrollment. Self-reported HRT use was assessed at study
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enrollment, but details of HRT routes and doses were not collected. To avoid effects of
medication changes, those using HRT at enrollment were confirmed to have been doing do for
at least six months, and those not using were asked to not begin during the study period. Subjects
were excluded if they had diabetes mellitus (fasting glucose > 140 mg/dl), hypertension (blood
pressure > 160/90 mmHg), known cardiovascular disease, or a musculoskeletal condition that
would prohibit exercise training. Additional, exclusion criteria included cigarette smoking, the
use of medications known to affect carbohydrate or lipid metabolism (including insulin, oral
anti-diabetic agents, HMG CoA reductase inhibitors or statins, fibric acid derivatives, bile acid
sequestrants, and nicotinic acid), and participation in a dietary regimen designed to induce
weight loss.
Exercise Training
Subjects were randomized to six months of continued inactivity or one of three aerobic exercise
groups: a) low-amount-moderate-intensity (caloric equivalent of approximately 12 miles/week
or 1200 kcal/week at 40 to 55% peak VO2), b) low-amount-vigorous-intensity (caloric
equivalent of approximately 12 miles/week or 1200 kcal/week at 65 to 80% peak VO2), or c)
high-amount-vigorous-intensity (caloric equivalent of approximately 20 miles/week or 2000
kcal/week at 65 to 80% peak VO2). Subjects randomized to exercise completed a two to three
month ramp period in order to minimize musculoskeletal injuries prior to the six months of
prescribed training. Subjects were counseled to maintain and not alter dietary intake throughout
the study. Dietary stability was confirmed with three-day food records and 24-hour dietary
recall interviews performed at baseline, during the intervention, and at the conclusion of the
study. Subject flow through STRRIDE and a detailed analysis of response in insulin sensitivity
by exercise training group have been previously published[2,14]. The original analysis of the
effect of exercise volume and intensity on insulin sensitivity was performed prior to the
conclusion of the study but once the accrued sample size was felt sufficient (n=154) for the
outcome of interest. Here, our primary analysis of interest was to identify the impact of HRT
use on change in insulin action with exercise training, and we included in these analyses all
subjects who completed six months of exercise training or inactivity and had insulin action
measurements at baseline and after completion of training (n=206).
Fitness, body composition, lipid, skeletal muscle, and insulin action
Each of these were evaluated at baseline (prior to ramp period) and after six months of inactivity
or prescribed exercise training in each subject. Exercise treadmill testing was used to assess
cardiorespiratory fitness. Adiposity and body composition measurements were performed as
previously described[2,13] – percent body fat was assessed as the sum of skin fold caliper
measurements; visceral adiposity (VAT) and subcutaneous adiposity (SAT) were measured
with a single slice abdominal CT scan at the level of the L4 vertebra[13,15]. Lipoprotein
analyses were performed via nuclear magnetic resonance spectroscopy using fasted plasma
samples (LipoScience, Cary, NC)[3].
Skeletal muscle biopsies were obtained from the vastus lateralis using a percutaneous needle
sampling technique.[16] Immunohistochemical techniques were used to determine skeletal
muscle capillary density by counting anti-CD31 stained endothelial cells in a minimum of three
100X magnification fields and a minimum of 100 muscle fibers as previously described[17].
Capillary density was expressed as capillaries per mm2 and capillaries per muscle fiber.
Skeletal muscle fiber area was also measured on a minimum of 100 fibers per sample.
Mitochondrial derived citrate synthase activity was determined with a fluorescent based
enzymatic assay using homogenized skeletal muscle[18].
Insulin action was assessed as previously described[2]. A three hour frequently sampled
intravenous glucose tolerance test (IVGTT)[19] was performed at baseline and 16 to 24 hours
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after the final exercise bout. After establishing intravenous access, fasting samples were
obtained and then glucose (50% at 0.3 g/kg body mass) was infused. At minute 20, insulin
(0.025 U/kg body mass) was injected. Blood samples were collected at minutes 2, 3, 4, 5, 6,
8, 10, 12, 14, 16, 19, 22, 25, 30, 40, 50, 60, 70, 80, 90, 100, 120, 140, 160, and 180. After
centrifugation, plasma was stored at ?80°C until measurements of insulin and glucose were
performed. Insulin was measured by immunoassay (Access Immunoassay System, Beckman
Coulter, Fullerton, CA) and glucose with an oxidation reaction (YSI Model 2300 Stat Plus,
Yellow Springs Instruments, Yellow Springs, OH). Using the minimal model of Bergman
[19], an insulin sensitivity index (SI) was calculated and reflects the ability of insulin to promote
glucose disposal and suppress glucose secretion. Normal values for SI have been reported as
2.62 ± 2.21 mU/L/min, and values below this normal range indicate insulin resistance[20].
Data Analysis
The main objective of this analysis was to identify whether gender and HRT use impact exercise
training-induced responses in insulin action. Variables not approximating a normal distribution
were logarithmically transformed prior to statistical analysis. Change scores were created for
each variable by subtracting the baseline value from the post-training value. Analyses including
HRT use incorporated a categorical variable with identifiers for each of women using HRT
(HRT+), women not using HRT (HRT?), and men. Gender and HRT use differences in insulin
action were assessed with analyses of variance followed by Tukey’s adjustment for multiple
comparisons.
Our secondary objective was to determine whether potential mediators of exercise training-
induced responses differ with respect to gender and HRT use. Linear modeling was preceded
by a variable reduction step whereby we a priori defined each of the following domains of
potential mediators: gender/HRT use, cardiorespiratory fitness, regional adiposity, general
adiposity, lipids, and skeletal muscle. Within each of these domains, the variable with the
largest significant correlation coefficient in the relationship with change in SI was selected as
the representative variable for that domain. Next, these six variables were used in linear
modeling. Given a concern for interactions between gender or HRT use and each of the
potential mediators, a full model containing each of the intermediates and each HRT
use*intermediate interaction term was fit. If none of the gender interaction terms was found
significant, these terms were removed, and the main effects model containing each of the six
potential mediators was refit. Final models were validated on 100 bootstrap replicates of the
original sample to investigate the robustness of the model and to address concerns about
possible overfitting.
Statistics were performed using SAS Enterprise Guide v8.2 (Cary, NC). Prior to analysis, we
established statistical significance as P<0.05 for all main effects and P<0.10 for interaction
terms, which require more power for detection.
Results
Baseline demographic and metabolic characteristics of this study population have been
reported previously[2,3,5], and there were no statistically significant differences in
demographic or baseline metabolic characteristics between exercise groups. Briefly, 67% of
subjects completed the investigation. Of these, 80% of participants were Caucasian, 17% were
African-American, 2% were Asian, and 1% was Hispanic. At baseline, there were no
statistically significant differences in metabolic characteristics between HRT+ and HRT?
women (Table 1). In contrast, men differed from both HRT+ and HRT? women in that they
were slightly younger, with greater cardiorespiratory fitness, and greater lean body mass, but
were less insulin sensitive, more dyslipidemic and had increased amounts of VAT (Table 1).
Additionally, relative to men, HRT? women had slightly lower BMIs and capillary density.
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Our primary objective was to determine whether HRT use influenced the response in SI with
exercise training. While no gender difference in SI response was noted (Figure 1A, P <0.71),
independent of group assignment, HRT+ women improved SI more than did HRT? women
(Figure 1B, P <0.003). We observed no significant group*HRT use interaction (P<0.96);
however, when exercise groups were analyzed separately, HRT? women demonstrated greater
improvements in SI with low-amount-moderate-intensity exercise training than with low-
amount-vigorous intensity training (P<0.04) or inactivity (P<0.007).
Given the previous finding, our secondary aim was to identify whether potential mediators of
response in insulin action would differ by gender and/or HRT use. We evaluated the
relationships between the change in SI other variables felt likely to influence response in SI
(Table 2). Using the variable reduction strategy and linear modeling described above, we
observed that when considered together gender/HRT use, SAT change, body mass change,
serum triglyceride change, and skeletal muscle capillary density (endothelial cells per fiber)
change, and cardiorespiratory fitness (relative peak VO2) change explained 18% of the variance
in the change in SI (P<0.005). By including gender/HRT interaction terms, the amount of
variance in change in SI explained by these potential mediators increased from 18% to 35%
(P<0.0001). In this model, HRT use*triglyceride change (P<0.03), HRT use*SAT change
(P<0.03), and HRT use*capillary density change (P<0.07) were each independently related to
change in SI. In the 100 bootstrap replicates of the sample, the mean ± standard deviation R2
for this model was 0.42 ± 0.10. The frequency of each of the interaction terms as independently
related to change in SI in the bootstrap procedure was as follows: HRT*SAT change 69%;
HRT*capillary density change 63%; HRT*triglyceride change 66%.
The above analyses indicate that HRT use and/or gender affect the relationship between the
change in SI and triglyceride change, capillary density change, and SAT change. In other words,
the relationships between change in SI and each of triglyceride change, capillary density
change, and SAT change were different depending on HRT use and gender. In order to illustrate
how HRT use and gender modified these effects, we depicted these relationships as scatter
plots that contain unique identifiers for men, HRT+ and HRT? women (Figure 2). As shown
in Figure 2A, SI change related to triglyceride change for HRT+ women but not for HRT?
women or men. For HRT? women, SI change related to capillary density, but no relationship
was evident for HRT+ women or for men. The relationship between SI change and SAT change
was limited to men; no relationship was present for women, irrespective of HRT use. These
results were verified with linear modeling performed separately for each gender. For women,
we were able to explain 40% of the variance in change in SI using HRT use, triglyceride change
and capillary density change. In contrast, for men, SAT change, the strongest single potential
mediator in men, explained only 10% of the variance in change in SI.
Discussion
Here, in a group of sedentary, dyslipidemic, overweight to mildly obese, middle-aged men and
women, we observed that the response of insulin sensitivity to exercise training differed for
men, post-menopausal women using HRT, and post-menopausal women not using HRT. Most
remarkably, we observed much more robust improvements in insulin sensitivity for women
using HRT than those not using HRT.
To our knowledge, this is the first report examining the effect of HRT use on insulin sensitivity
responses to a randomized controlled exercise intervention. The observation that post-
menopausal HRT+ women show significantly greater improvements in insulin sensitivity with
exercise training than do post-menopausal HRT? women has important implications for
scientific investigation and clinical care. Our observation highlights the need for careful
attention to exogenous hormone use in investigations relating exercise training and responses
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in insulin action. Alternatively, our findings suggest that in investigations relating HRT use
and surrogates for cardiovascular risk, physical activity needs to be carefully assessed.
Since the increased risks of cardiovascular disease, stroke, and breast cancer with the use of
exogenous estrogen/progesterone combinations in women were revealed, there has been a
substantial reduction in HRT use[10–12]. For the majority of post-menopausal women not
currently using HRT, our observations suggest that an exercise prescription designed to
improve insulin sensitivity, such as those in the present study, might be optimized by following
a low-amount-moderate intensity regimen rather than a regimen of higher intensity but with
less time spent exercising. Moreover, our observations represent yet another example of the
paradox between the potentially beneficial effects of HRT on metabolic cardiovascular risk
markers in women, but the well established detrimental effects of HRT use on hard
cardiovascular outcomes in post menopausal women.
Estrogen has been shown to exhibit multiple effects which may drive enhanced improvements
in insulin sensitivity with exercise training. Since insulin sensitivity change related to
triglyceride change for HRT+ but not for HRT? women, it is possible that at least a proportion
disparity in change in the insulin sensitivity for HRT users and nonusers results from the first
pass hepatic effects of oral HRT on triglyceride concentrations. Interestingly, in HRT+ women,
triglyceride concentrations have been found to both decrease[21,22] and increase[23] with
exercise training in previous studies. The discordant findings among these studies is likely
related to significant differences in exercise training protocols, doses and routes of HRT among
these investigations[23], and genetic determinants. Additionally, HRT-driven exercise-
induced insulin sensitivity changes may be due to effects of estrogen metabolites on skeletal
muscle glucose uptake signaling pathway component such as AMP kinase[24], Akt[24,25],
and insulin receptors[26].
For HRT? women, capillary density change was the potential mediator related most strongly
with insulin sensitivity change. Since capillaries deliver insulin and glucose to skeletal muscle
cells and skeletal muscle is the principal site for glucose uptake[27], it is physiologically
relevant that changes in capillary density were indicative of insulin sensitivity response. In
contrast, we were perplexed to find that this potential mediator was not related to insulin
sensitivity change in HRT+ women or men.
Central adiposity changes were best related to change in insulin sensitivity for men. Of these,
SAT change, specifically, abdominal SAT change, demonstrated the best relationship with
insulin sensitivity change. Given the recent emphasis on intra-abdominal VAT, we found it
notable that SAT change was related more strongly than VAT change to the insulin sensitivity
response to exercise training. While we believe that VAT is an important and metabolically
active reservoir, our data and those of others[28,29] remind us that SAT is also a very important
contributor to metabolic health, particularly in men. The superior relationship between SAT
and insulin sensitivity may be attributed to the contribution of SAT to a larger proportion of
total central adiposity[29,30], but may also reflect the critical importance of the saturation of
SAT, both the superficial and deep reservoirs, as a mediator of insulin resistance. Further, this
observation emphasizes the utility of surrogate measures, such as waist circumference, as an
indication of metabolically important central adiposity stores that can be easily implemented
in the clinic and used to monitor response to exercise training, at least in men.
One recognized weakness of this work is that HRT use was not blinded or placebo controlled.
Additionally, we have limited information about the doses, routes and duration of HRT use in
these individuals. However, given the current controversy surrounding HRT use, it is unlikely
that an intervention optimally designed to answer this question will be feasible. Nonetheless,
our observations strongly imply that physiologic responses to exercise differ with respect to
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gender and HRT use. Additionally, in this investigation, we cannot account for genetic
determinants of responses to HRT and exercise training. Future attempts to dissect mechanisms
of alterations in insulin action with exercise training should consider genetic contributions and
address such differences by gender and estrogen status.
In sum, in this investigation of middle aged, moderately overweight to obese men and women,
we observed that women using HRT improve insulin sensitivity with exercise training more
robustly than do women not using HRT. In fact, only moderate intensity exercise led to
improvements in insulin sensitivity in women not using HRT. We observed that predictors for
exercise-induced responses in insulin sensitivity were different for men (subcutaneous central
adiposity), for women not using HRT (skeletal muscle capillary density), and for women using
HRT (serum triglycerides). These observations represent yet another example of the paradox
between the potentially beneficial effects of HRT on metabolic cardiovascular risk markers in
women and the well established detrimental effects of HRT use on hard cardiovascular
outcomes in post menopausal women. All of these observations command attention when
generating exercise training prescriptions for sedentary middle-aged to elderly men and women
when anticipating improvements in insulin action and a delay in development of overt type 2
diabetes.
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Figure 1. Gender and Hormone Replacement Therapy (HRT) Use and Exercise Training Responses
in Insulin Sensitivity
Subjects (n=206) were randomized for six months to inactivity (nmen= 12, nwomen HRT?=10;
nwomen HRT+=5) or one of three aerobic exercise training groups: Low-Amount Moderate
Intensity (Low-Mod; nmen= 30, nwomen HRT?=11; nwomen HRT+=16); Low Amount-Vigorous
Intensity (Low-Vig; nmen= 33, nwomen HRT?=15; nwomen HRT+=10); High-Amount Vigorous
Intensity (High-Vig; nmen= 38, nwomen HRT?=11; nwomen HRT+=15)
A. Change in insulin sensitivity by group and gender was assessed with a two-way analysis of
variance (P<0.71). Black bars depict men, and white bars depict women (HRT? and HRT+
combined).
B. Change in insulin sensitivity by group and hormone therapy use was assessed with a two-
way analysis of variance. Black bars depict men; white bars with diagonal lines depict HRT?
women; and white bars with dots depict HRT+ women. Both group (P<0.005) and HRT use
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(P<0.005) were independently related to change in insulin sensitivity. Error bars represent
standard error.
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Figure 2. Relationships for Insulin Sensitivity Change by Gender and Hormone Replacement
Therapy (HRT) Use
Standard correlations were performed for men (n=113), HRT? women (n=47), and HRT+
women (n=46). Men are identified with solid squares and a solid regression line. HRT? women
are depicted with open triangles and a heavy dashed regression line. HRT+ women are depicted
with open circles and a light dashed regression line. Regression lines are illustrated for only
those relationships found significant (P<0.05).
A. Triglyceride change is related to change in insulin sensitivity change for HRT+ women
(P<0.05).
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B. Capillary density change is related to change in insulin sensitivity for HRT? women
(P<0.05).
C. Subcutaneous adiposity change is related to change in insulin sensitivity for men (P<0.05).
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Table 1
Baseline Demographic and Metabolic Characteristics*
Men n=113 Women HRT ?
n=47
Women HRT +
n=46
Demographics Age 50.7±6.9† 54.7±5.3 53.7±5.6
Exercise training Adherence (%) 88.2±14.6 86.4±10.2 86.4±16.0
Insulin Sensitivity
(SI) (mU/L/min)
2.31±2.00† 3.25±1.95 3.28±1.69
Cardiorespiratory fitness
Time to exhaustion (sec) 868±167† 644±179 615±140
Absolute Peak VO2 (ml/min) 2.98±0.52† 1.90±0.27 1.78±0.24
Relative Peak VO2 (ml/kg/min) 31.4±4.9† 23.7±3.7 23.3±3.6
Regional adiposity
Visceral adiposity (cm2) 193.6±64.9† 139.7±53.4 126.7±53.9
Subcutaneous adiposity (cm2) 284.8±93.7 321.8±105.7 302.0±100.2
Minimal waist (cm) 101.5±7.3† 91.3±8.9 87.7±7.2
Umbilical waist (cm) 106.2±7.9† 102.0±11.4 98.7±9.5
General adiposity
Body mass index (kg/m2) 30.1±2.8 30.2±3.2 28.8±2.9**
Lean body mass (kg) 67.3±7.8† 49.7±6.1 47.9±6.3
Serum lipoproteins
LDL particle concentration (nmol/L) 1431±1 1315±1 1371±1
LDL particle size (nm) 20.4±1.0† 21.2±1.1 21.2±1.0
HDL- cholesterol (mmol/L) 37.4±1.3† 48.3±1.3 54.7±1.3
Triglyceride (mmol/L) 158.2±1.7† 112.3±1.6 114.4±1.6
Skeletal muscle parameter
Capillary density (endothelial
cells:fiber)
1.63±1.26 1.52±1.19 1.41±1.17**
Capillary density (#/mm2) 345.0±1.1 319.7±1.2 298.0±1.2**
Fiber area (?m2) 4557.5±1.1† 3707.0±1.1 3539.9±1.1
Citrate synthase activity (?mol/min/?g) 0.20±1.9 0.17±2.5 0.21±1.8
*
Means ± standard deviations presented; for those without normal distributions, geometric means and standard deviations are presented.
Exercise training adherence = Completed/prescribed miles per week*100
ᒷ
Differs from other groups with Tukey’s post-hoc testing p<0.05
**
Differs from men with Tukey’s post-hoc testing p<0.05
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